Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

Arellano-Rodrigo, Eduardo; Garrote Ordeig, Marta; Martín, Iván; GOMEZ CASARES, MARIA TERESA; Mosquera Orgueira, Adrián; Pérez-Encinas, Manuel; Fox, Maria Laura

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Arellano-Rodrigo, Eduardo
dc.contributor.author	Garrote Ordeig, Marta
dc.contributor.author	Martín, Iván
dc.contributor.author	GOMEZ CASARES, MARIA TERESA
dc.contributor.author	Mosquera Orgueira, Adrián
dc.contributor.author	Pérez-Encinas, Manuel
dc.contributor.author	Fox, Maria Laura
dc.date.accessioned	2024-03-22T09:25:10Z
dc.date.available	2024-03-22T09:25:10Z
dc.date.issued	2024-03-20
dc.identifier.citation	Mosquera-Orgueira A, Arellano-Rodrigo E, Garrote M, Martín I, Pérez-Encinas M, Gómez-Casares MT, et al. Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis. HemaSphere. 2024 Mar 20;8(3):e60.
dc.identifier.issn	2572-9241
dc.identifier.uri	https://hdl.handle.net/11351/11222
dc.description	Predictores moleculares; Pronóstico; Mielofibrosis
dc.language.iso	eng
dc.publisher	Wiley
dc.relation.ispartofseries	HemaSphere;8(3)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Mielofibrosi - Prognosi
dc.subject	Anomalies cromosòmiques
dc.subject	Mielofibrosi - Tractament
dc.subject	Intel·ligència artificial - Aplicacions a la medicina
dc.subject.mesh	Mutation
dc.subject.mesh	Primary Myelofibrosis
dc.subject.mesh	/therapy
dc.subject.mesh	Prognosis
dc.subject.mesh	Artificial Intelligence
dc.title	Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1002/hem3.60
dc.subject.decs	mutación
dc.subject.decs	mielofibrosis primaria
dc.subject.decs	/terapia
dc.subject.decs	pronóstico
dc.subject.decs	inteligencia artificial
dc.relation.publishversion	https://doi.org/10.1002/hem3.60
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Mosquera‐Orgueira A, Pérez‐Encinas P] Santiago de Compostela, Hospital Clínico Universitario, Valencia, Spain. [Arellano-Rodrigo E, Garrote M] Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. [Martín I] Hospital Clínico Universitario-INCLIVA, Univercitat de Valencia, Valencia, Spain. [Gómez‐Casares MT] Hospital Dr Negrín, Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain. [Fox ML] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid	38510992
dc.rights.accessrights	info:eu-repo/semantics/openAccess